Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
27 results
D2.17 - Prostate-Specific Protein Can f 5 as an Allergen in Seminal Fluid Hypersensitivity: A Case Study
D2.18 - Identification of Potential Allergens in Lobularia maritima: A Case Study
D2.20 - Chronic Idiopathic Urticaria with the presence of Helicobacter pylori infection-clinical and laboratory data correlation
D2.22 - Evaluating the Role of Telemedicine in Allergy Care: Patient Preferences and Experiences
D2.23 - The Natural Course Of Allergic Rhinitis In Cat Owners With Cat Allergy
D2.24 - Vicilins – an overlooked group of storage protein allergens in walnut and hazelnut
D2.25 - The spectrum of sensitization in atopic dermatitis in patients living in the Far East of Russia
D2.26 - Analysis of Sensitization Profiles and Cross-Reactivity of Lipocalin Allergens in Czech Allergy Patients
D2.27 - Interregional differences in molecular profiles of sensitization to respiratory allergens in the Russian population
D2.28 - Interregional differences in the prevalence of sensitization to food allergens in different regions of Russia
D2.29 - Assessing Individual Pollen Allergies Using Self-reported Real-World Allergy Burden Data
D2.30 - Combined sensitization among patients with allergic rhinitis and bronchial asthma: changes during the war in Ukraine
D2.31 - An Unexpected Easter Surprise: Anaphylaxis Triggered by Colored Candy Eggs
D2.32 - Assessment of local nasal IgE in patients with suspected dual allergic rhinitis before and after nasal allergen provocation – presentation of 6 cases
D2.294 - Allergic contact dermatitis unit at Hospital Joan XXIII (Tarragona, Spain): descriptive analysis 2022 - 2023
D2.295 - Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters
D2.296 - Allergic contact dermatitis caused by a oxybutynin in a transdermal patch
D2.297 - SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria
D2.299 - A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway
D2.300 - Fixed Drug Eruption related to the use of NSAIDs
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download